IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ekema, G. M.
Right arrow Articles by Lu, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ekema, G. M.
Right arrow Articles by Lu, L.
(Investigative Ophthalmology and Visual Science. 2002;43:2326-2333.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Interaction of GABA Receptor/Channel {rho}1 and {gamma}2 Subunit

George M. Ekema, Wei Zheng and Luo Lu

From the Division of Molecular Medicine, Harbor-UCLA Medical Center, School of Medicine, University of California Los Angeles, Torrance, California.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
PURPOSE. To determine whether protein–protein and functional interactions can occur between {gamma}-aminobutyric acid (GABA)A receptor/channels {gamma}2 subunit and the retina-specific GABAC {rho}1 subunit.

METHODS. Protein–protein interaction was characterized by immunocoprecipitation of these subunits in brain and spinal cord with anti-{gamma}2 subunit antibody and by Western blot analysis with anti-{rho}1 subunit antibody. The {rho}1 and {gamma}2 subunits were detected in the adult rat brain and spinal cord lysates that had been previously precipitated with the specific antibodies against the {rho}1 and {gamma}2 subunits, respectively. A two-microelectrode voltage clamp was used to measure GABA-induced currents in oocytes. In addition, a yeast two-hybrid system was used to detect the interactions of these subunits in vivo.

RESULTS. Based on yeast transformed with the N-terminal fragment of the {gamma}2 subunit ({gamma}2-N'), the N-terminal fragment of the {rho}1 subunit ({rho}1-N'), and the full-length {rho}1 subunit, the protein–protein interaction of the GABAA {gamma}2 subunit and the GABAC {rho}1 subunit was found in yeast grown in triple-dropout medium (deficient in Leu, Trp, and His) and expressing the LacZ reporter gene. Interaction of the {rho}1 and {gamma}2 subunits was investigated by functional studies in which {gamma}2 ({gamma}2-N' with 837 bp) and {rho}1 cRNAs were coinjected in Xenopus oocytes. In studies of the functional interaction, after injection of the {gamma}2 subunit mutant cRNA containing a N-terminal fragment, GABA-induced {rho}1 originated currents declined to 16% of the control level of homooligomeric {rho}1 current. This inhibitory effect of coexpressing {gamma}2 subunit mutants with {rho}1 subunit on the {rho}1-originated current in oocytes was dose dependent. In addition, coexpression of the GABA {rho}1 and {gamma}2 subunits in oocytes altered pharmacologic properties of the homooligomeric receptor/channel formed by {rho}1 or {gamma}2 subunits. Further evidence was provided by results obtained with specific antibodies showing that the {rho}1 subunit was coimmunoprecipitated with the {gamma}2 subunit from the retina, brain, and spinal cord.

CONCLUSIONS. The results indicate that protein–protein and functional interactions can occur between the GABAA {gamma}2 subunit and the GABAC {rho}1 subunit. Therefore, the functional role of GABA receptor/channels in the brain, retina, and spinal cord is more diversified because of the possible assembly between the GABAA {gamma}2 subunit and GABAC {rho}1 subunit.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
A major inhibitory neurotransmitter in the vertebrate central nervous system (CNS) is {gamma}-aminobutyric acid (GABA). Its cognate receptors have been classified into three distinct subtypes based on their pharmacologic properties. The GABAA receptor/channel is bicuculline sensitive, the GABAB receptor is baclofen sensitive, and the GABAC receptor/channel is insensitive to either bicuculline or baclofen. However, the current classification of GABA receptors does not completely describe GABA receptor/channel heterogeneity, based on pharmacologic profiles of diseases of the GABAergic system, GABA receptor/channel subunit distributions in the CNS, and electrophysiology of the GABA receptor/channel in vivo.1 2 3 4 5 6 7 8 GABA receptor/channel heterogeneity in the mammalian CNS is due to interactions among at least 21 different subunits, including {alpha}1 to {alpha}6, ß1 to ß4, {gamma}1 to {gamma}4, {delta}, {omega}, {pi}, {zeta}, and {rho}1 to {rho}3.9 10 11 12 13 14 15 16 17 18 19 20 Composition of different subunits in the receptor/channel determines the pharmacologic and electrophysiological properties of GABA receptors-channels.10 12 20 21 22 Analysis of molecular structure of GABA receptors-channels reveals that subunits assemble in a putative pentameric heterooligomeric combination to form the receptor/channel.23 The GABAC {rho}1 subunit, cloned from the human retina, forms functional homooligomeric receptor channels when expressed in Xenopus oocytes.11 The {rho}1 subunit was initially reported to be a retina-specific GABA receptor/channel, exclusively localized in the retina.24 However, distribution of the {rho}1 subunit is not limited to the retina; it has also been reported in the CNS25 in the hippocampus,26 27 cerebellum,28 29 anterior pituitary,1 dorsal root ganglia,30 and optic tectum.31

The molecular structure of GABAA receptor/channel complex is thought to be a heteropentomeric glycoprotein of approximately 275 kDa composed of combinations of multiple peptide subunits.32 This has been deduced from Western blot, immunoprecipitation, immunoaffinity chromatography, and in situ hybridization. Topologic structure of GABA receptor/channel is predicted from the structure of another ligand-gated receptor/channel.33 The functional heterogeneity of GABAA receptors in neurons arises, not only from the multiple GABA receptor/channel subunit genes and splice variants, but also from the combinatorial mixing of different GABA receptor/channel polypeptides to form heterooligomeric receptor/channels.16 34 35 36 37 38 Various GABAA receptor/channel subunits are differentially expressed during specific developmental stages and under varying physiological conditions in different regions of the body.11 39 40 These considerations may contribute to the diversity seen in GABA receptor/channel pharmacology and function. If heterooligomeric receptors were formed by random combinations, it would create numerous GABA receptor/channel isoforms. In fact, functional GABAA receptor/channels always exist in preferred subunit combinations, as mentioned earlier.33 GABA {alpha}1ß2/3{gamma}2 and {alpha}2ß2/3{gamma}2 receptor/channels represent two major GABAA receptor subtypes contributing to 75% to 85% of the diazepine-sensitive GABAA receptors.10 It has been shown that different subunits do not have the same assembly behavior.35 41 GABAC {rho}1 or {rho}2 subunits can form homooligomeric receptors and express robust currents in oocytes.11 42 However, sole expression of a single GABAA receptor subunit in oocytes results in a much smaller GABA-induced current compared with heterooligomeric expression, suggesting a low efficiency for GABAA subunits to form homooligomeric channels in oocytes.35 41 GABA receptor/channel assembly involves several posttranslation maturation steps and is driven by noncovalent protein–protein interaction.43 There are specific recognition sites on the individual subunit that guides their proper assembly into a functional receptor/channel. However, structural elements that determine the compatibility for the subunit assembly are still unknown.

Recently, electrophysiological studies of recombinant GABA receptor/channels in Xenopus oocytes suggest that GABA {gamma}2 and {rho}1 subunits may form a functional receptor/channel in oocytes.44 45 46 However, there is no direct evidence that demonstrates the assembly of a heterooligomeric receptor/channel between GABA {gamma}2 and {rho}1 subunits at protein–protein interaction level in vitro and in vivo. In the present study, we report that both protein–protein and functional interactions can occur between the retinal specific GABAC {rho}1 subunit and GABAA{gamma}2 subunit. This determination is based on our results in studies in which immunoprecipitation, the yeast two-hybrid system, and electrophysiological measurements in the oocyte expression system were used. The first approach indicates that {rho}1 and {gamma}2 subunits can interact, because it was possible to immunoprecipitate the {rho}1 subunit from the retina, brain, and spinal cord lysates with an antibody selective for the {gamma}2 subunit. Further evidence for protein–protein interaction is that in the yeast two-hybrid system {rho}1 and {gamma}2 interaction occurred based on elicited gene expression. Such an interaction is reflective of a very specific assembly process occurring in vivo. Furthermore, coexpression of the {rho}1 subunit along with an N-terminal fragment of the {gamma}2 subunit occurred in Xenopus oocytes, because increases in {gamma}2 subunit expression inhibited homooligomeric {rho}1-originated currents in a dose-dependent pattern.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Immunoprecipitation and Western Blot Analysis
The protocol of the study adhered to the provisions of the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Whole brain, retina, and spinal cord from adult albino rats were lysed with lysis buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 10 mM sodium pyrophosphate, 10% glycerol, 1% Triton X-100, 1 mM NaF, 1 mM Na-orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 250 µM p-nitrophenylphosphate, 10 µg/mL aprotinin, and 10 µg/mL leupeptin. Cell lysates were centrifuged at 5000 rpm for 5 minutes, and the supernatant was transferred to a new tube containing anti-{gamma}2 antibody (polyclonal IgG from rabbit against the N terminus of the {gamma}2 subunit) plus protein a affinity medium (Protein A Sepharose beads; Sigma, St. Louis, MO) and incubated overnight at 4°C.47 Final dilution of the anti-{gamma}2 antibody was 1:15,000. Cell lysates were centrifuged at 5000 rpm for 5 minutes, and the precipitate was boiled in an equal volume of SDS-PAGE sample buffer for 5 minutes. Aliquots were loaded on SDS-PAGE gels followed by Western blot analysis, using a 1:10,000 dilution of anti-{rho}1 antibody (polyclonal IgG from guinea pig against the N terminus of the {rho}1 subunit) for the detection.47 Briefly, an equal volume of 2x Laemmli buffer was mixed with the immune complex and boiled for 5 minutes. After resolution by SDS-PAGE, proteins were transferred to polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA) and probed with antibodies against specific subunits. Membranes were then incubated with secondary antibodies conjugated with alkaline phosphatase. Secondary antibodies were detected with a Western blot detection kit (Phototope-Star; New England Biolabs, Beverly, MA).

Yeast Two-Hybrid cDNA Construction and Transformation
cDNAs of the N termini ({gamma}N' and {rho}N', see the Results section) were subcloned into the yeast expression vector (pACT2; Clontech, Palo Alto, CA) encoding a GAL4 transcriptional activation domain (AD) of the yeast Saccharomyces cerevisiae. Full-length {rho}1 cDNA was subcloned into a yeast expression vector (pAS2-1; Clontech) encoding the GAL4 DNA-binding domain (BD). The orientation and alignment of the reading frame for the subcloned cDNAs were confirmed by DNA sequencing. The yeast two-hybrid system (Matchmaker; Clontech) was used to determine interaction of the GABAA receptor/channel {gamma}2 subunit with the GABAC receptor/channel {rho}1 subunit. Reporter yeast (strain Y190; Clontech)-competent cells were prepared by the lithium acetate method. Yeast cells were cultured overnight at 30°C with shaking at 250 rpm in 50 mL of medium (YPD; Clontech) and diluted in 300 mL of the medium to an optical density at 600 nm (OD600) of 0.2. Yeast cells were centrifuged and rinsed in water at room temperature. They were resuspended in 1.5 mL of TE (Tris-EDTA) buffer/lithium acetate (TE/LiAC; Clontech). Full-length {rho}1 (2.05 kbp) in pAS2-1 was simultaneously transformed into the Y190 cells with each of the N termini {gamma}2 ({gamma}N', 0.84 Kbp) and {rho}1 ({rho}N', 0.80 kbp) in the pACT2 vector. Each plasmid DNA (100 µg) was added to 100 µg herring testes carrier DNA. Yeast cells were heat shocked for 15 minutes in a 42°C water bath, spun down, and resuspended in 0.5 mL TE buffer. Transformation mixture was spread on 100-mm plates containing a synthetic dropout (SD) selection medium without leucine, tryptophan, and histidine (-Leu/-Trp/-His), supplemented with 25 mM 3-amino-1,2,4-triazole (+3-AT; Sigma, St. Louis, MO). Plates were incubated at 30°C for 2 to 4 days. For LacZ selection, only fresh colonies (3 days in culture) on SD/-Leu/-Trp/-His/+25 mM 3-AT agar plates were assayed. Assayed colonies were transferred onto filter paper and then submerged in liquid nitrogen for 10 seconds each time, followed by 1 minute of thawing. Each filter was placed, colony side up, on a presoaked filter and incubated at 30°C.

Construction of {gamma}2 and {rho}1 N-Terminal Domains
Construction of N-terminal {gamma}2 and {rho}1 subunits was based on analysis of the full-length DNA subunit sequences.11 18 48 49 N-terminal fragments were amplified by PCR from full-length sequences inserted into a vector (pBluescript SK(-; Stratagene, La Jolla, CA) vector. PCR primers were designed as follows: 5'-GGA TCCGGCGAGAGGAAAAAAAAGCG-3' with an introduced BamHI restriction enzyme site ({gamma}2 sense); 5'-GATCTGAGCAGAAGAATGGGGCTCGAG-3' with an introduced XhoI restriction enzyme site ({gamma}2 antisense); 5'-GGATCCCCATGTTGGCTGTCCCA-3' with an introduced BamHI restriction enzyme site ({rho}1 sense); 5'-ccccgctaccctgatggtcatgGGATTC-3' with an introduced EcoRI restriction enzyme site ({rho}1 antisense). Each N-terminal fragment was subcloned into the multicloning site (MCS) of a PCR3 vector.

In Vitro Transcription and Microinjection of Oocytes
Fragments of subunit cDNAs for in vitro transcription were subcloned into the multiple cloning site of a PCR3 expression vector in an orientation of T7 to SP6. Plasmid constructs with inserts were linearized with PstI (New England Biolabs). A T7 in vitro transcription kit (Invitrogen, San Diego, CA) was used in all transcription reactions. Transcription reactions were performed in the presence of the cap analogue diguanosine triphosphate, and were catalyzed by T7 RNA polymerase. The cRNA was quantified by agarose gel electrophoresis and photospectroscopy (Pharmacia, Piscataway, NJ), and then dissolved in sterile RNase-free water to a final concentration of 5 µg/µL. Xenopus oocytes were prepared from frogs by using a method described previously.47 Stage 5 to 6 oocytes were selected and incubated at 18°C in MBS (Modified Barth’s Solution) for 24 hours, followed by injection of cRNA. Microinjection of cRNA into oocytes was performed by positive displacement with a 10-µL micropipette (Drummond Scientific Inc., Broomall, PA).

Voltage Clamp
Two-microelectrode voltage-clamp recordings were performed at room temperature with continuous perfusion (10 mL/min). The glass microelectrodes (resistance ~2.0 M{Omega}) were made with a horizontal puller (PD-5; Narishige USA, Greenvale, NY), and were backfilled with 3 M KCl. The perfusion bath was connected to the voltage-recording amplifier (Axoclamp 2A; Axon Instruments, Burlingame, CA) by an Ag-AgCl-Agar-3 M KCl bridge. Data were filtered with a four-pole Bessel filter at 500 Hz. Data acquisition was performed with the pCLAMP software (Axon Instruments).

Statistical Analysis
Data were presented as original values, or as the mean ± SE. Significant differences were determined by using the paired t-test or ANOVA and the Tukey post-hoc range test at the confidence interval indicated.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Construction of N-Terminal Domain of the {rho}1 and {gamma}2 Subunits
It has been suggested that the N-terminal part of ligand-gated channels has a large extracellular domain containing ligand-binding sites.50 51 Its C-terminal part is believed to traverse the cell membrane and to form four transmembrane segments with a large intracellular loop between the third and fourth transmembrane segments. The second transmembrane region is likely to form the lining of the channel pore. The intracellular loop contains specific sites for channel regulation by protein kinase-induced phosphorylation. In the present study, N-terminal constructs of the {rho}1 and {gamma}2 subunits were composed of 292 and 271 amino acids, respectively (Fig. 1) . These N-terminal domain peptides were also used to produce fusion proteins in bacteria, by using a glutathione S-transferase (GST) fusion system. N-terminal domain fusion proteins were then used to raise specific antibodies against the {rho}1 and {gamma}2 subunits that demonstrate tissue and functional specificity.47



View larger version (16K):
[in this window]
[in a new window]
  		Figure 1. Putative structures of N-terminal domain of the {rho}1 and {gamma}2 subunits. The cDNA fragments encoding 292 and 271 amino acids (aa) of {rho}1 and {gamma}2 subunits, respectively, were amplified with PCR, using the full-length cDNA of {rho}1 and {gamma}2 subunits.

 
Immunoprecipitation of the Retinal {rho}1 Subunit from the Rat Brain and Spinal Cord
Immunoprecipitation experiments were performed to determine a protein–protein interaction between GABA {gamma}2 and {rho}1 subunits in the mammalian CNS. Brain and spinal cord lysates from adult rats were obtained and incubated with specific antibodies against the GABA {gamma}2 subunit. Brain and spinal cord proteins that were pulled down by the anti-{gamma}2 subunit antibody were analyzed in a polyacrylamide gel. A 50-kDa band was recognized by the anti-{rho}1 subunit antibody in the brain and spinal cord, but not in the control lanes in which brain and spinal cord proteins were immunoprecipitated with an anti-Erk (mitogen-activating protein [MAP] kinase) antibody (Fig. 2A) . Western blot analysis was used to detect {gamma}2 subunits in brain and spinal cord lysates that had been immunoprecipitated with the selective {gamma}2 antibody. A 48-kDa band was detected by the anti-{gamma}2 antibody in the brain and spinal cord tissues, but not in lysates immunoprecipitated in the control experiment with the anti-Erk antibody (Fig. 2B) . In addition, the retinal lysate from adult rats was used to incubate with the antibody against the GABA {gamma}2 subunit. Western blot analysis demonstrated that there was a 50-kDa band in the retina identified by the anti-{rho}1 antibody (Fig. 2C) . Protein bands with molecular weights of 48 and 50 kDa identified in Western blot by anti-{gamma}2 and anti-{rho}1 antibodies are consistent with the sizes of GABA {gamma}2 and {rho}1 subunits, respectively. These results suggest that there is indeed interaction and assembly of the {gamma}2 and {rho}1 subunits in the CNS.



View larger version (37K):
[in this window]
[in a new window]
  		Figure 2. Determination of interaction between GABA {gamma}2 and {rho}1 subunits in the brain and spinal cord. (A) Immunoprecipitation of the {rho}1 subunit from rat brain (BR) and spinal cord (SC) using anti-{gamma}2 antibody. Whole-brain and spinal cord lysates from adult albino rats were incubated overnight at 4°C with a 1:15,000 dilution of anti-{gamma}2 antibody in a protein A–affinity column. The {rho}1 subunit (~50 kDa) was detected in Western blot analysis of both precipitates, with anti-{rho}1 antibody. (B) The {gamma}2 subunit (~48 kDa) was detected in Western blot analysis of the immunoprecipitates from rat brain and spinal cord, with the same anti-{gamma}2 antibody that was used to pull down the precipitate. (C) Immunoprecipitation of the {rho}1 subunit from rat brain and retina (RT), with anti-{gamma}2 antibody. Whole-brain and retinal lysates from adult albino rats were incubated overnight at 4°C with a 1:15,000 dilution of anti-{gamma}2 antibody in a protein A–affinity column. The {rho}1 subunit (~50 kDa) was detected in Western blot analysis of both precipitates using anti-{rho}1 antibody. In these experiments, an anti-Erk antibody (polyclonal IgG from rabbit) was used for the negative control. This antibody did not pull down any proteins that could be detected by the anti-{rho}1 or the anti-{gamma}2 antibody.

 
Next, we tested whether an interaction between the {gamma}2 and {rho}1 subunits occurs as a posttranslational subunit–subunit interaction. To probe this possibility, GST-{rho}1 fusion protein containing the N-terminal part of the {rho}1 subunit was purified using a glutathione-Sepharose matrix. Lysates of the brain and spinal cord from adult albino rats were incubated with GST-{rho}1 fusion proteins that were bound to GST affinity matrix. Oocytes expressing {rho}1 subunit were also incubated with GST-{rho}1 fusion proteins. After the fusion protein and affinity matrix were rinsed with cold PBS, GST-{rho}1 fusion proteins were eluted from the affinity matrix with a glutathione elution buffer and subjected to Western blot analysis. The anti-{rho}1 antibody was used to probe for interaction of the GST-{rho}1 fusion protein and native {rho}1 subunit from the brain and spinal cord (Fig. 3A) and the GST-{rho}1 fusion protein and expressed {rho}1 subunit from cRNA-injected oocytes (Fig. 3B) . In addition, lysates from brain and spinal cord tissues, and from cRNA-injected oocytes were immunoprecipitated with anti-Erk antibodies and probed with the anti-{rho}1 antibody for the control, respectively. Western blot analysis demonstrated that GST-{rho}1 fusion proteins used in these precipitation experiments were detectable, but native {rho}1 subunit peptides were not detected. These results imply that {gamma}2 and {rho}1 subunit interaction or assembly in the CNS is unlikely to be a posttranslational event.



View larger version (32K):
[in this window]
[in a new window]
  		Figure 3. Determining interaction of GABA {rho}1 subunit fusion protein with GABA {gamma}2 subunit from the brain and spinal cord or from exogenous expression in oocytes. (A) Brain and spinal cord lysates from adult albino rats were pooled and incubated with GST-{rho}1 fusion protein that was bound to a GST affinity matrix. After it was raised with PBS, anti-{rho}1 antibody was applied to detect the 63-kDa GST-{rho}1 fusion protein in Western blot, but native {rho}1 protein from the brain and spinal cord was not detected. (B) Homogenates of Xenopus oocytes expressing the GABA {rho}1 subunit were incubated with GST-{rho}1 fusion protein that was bound to a GST affinity matrix. After it was raised with PBS, anti-{rho}1 antibody was used to detect the 63-kDa GST-{rho}1 fusion protein in Western blot, but the {rho}1 subunit protein expressed in Xenopus oocytes was not detected. Immunoprecipitated lysates from brain and spinal cord tissues (A) and from cRNA injected oocytes (B) with anti-Erk antibodies served as the control in Western blot analysis.

 
Protein–Protein Interaction of {gamma}2 and {rho}1 Subunits in the Yeast
To further confirm protein–protein interaction between GABA {gamma}2 and {rho}1 subunits in vivo, a high-fidelity yeast two-hybrid expression system was used. In the reporter yeast strain Y190, expression of the His-3 and LacZ reporter genes requires the DNA BD and AD of the GAL4 to be colocalized upstream from the activation sequence of GAL4. In addition, we fused full-length {rho}1 to the DNA BD, whereas {gamma}2N' and {rho}1N' terminal fragments were fused to the transcriptional AD of the yeast GAL4 transcriptional activator. The colocalization is mediated in yeast by the specific interaction of these fusion proteins that were connected to the AD and BD. In addition, 3-amino-1,2,4-triazole (3-AT) was added to the triple-dropout medium to prevent leaky His-3 activity, thereby ensuring the fidelity of the system. Thus, activation of transcription of the His-3 and LacZ reporter genes in our two-hybrid assay was due to the specific interaction of the {gamma}2 or {rho}1 N'-terminal fragment and {rho}1 subunit that were fused to the AD and BD, respectively. The 5-bromo-4-chloro-3-indolyl-ß-D-galactoside (X-gal) reaction (detection of LacZ reporter gene expression) was also used as the other indication of the interaction between AD and BD fusion proteins. The X-gal reaction ensures that survival of transformed yeast grown in SD-Leu/-Trp/-His selection medium is due to transcription of the His-3 reporter gene, not to external histidine contamination.

Y190 cells were simultaneously transformed with {rho}1-BD cDNA and each of the {gamma}2N'-AD and {rho}1N'-AD cDNA, in turn, and the transformation mixture was plated on SD-Leu/-Trp/-His/+25 mM 3-AT agar medium. Results shown in Table 1A indicate that in both transformations there was significant growth of Y190 primary colonies. The {rho}1N'/{rho}1 transformation was used as the positive control, because their interaction has been extensively characterized. Control experiments were also performed by simultaneously transforming yeast with antisense {rho}1-BD cDNA and {gamma}2N'-AD or by {rho}1N'-AD cDNA and by plating transformation mixture on SD-Leu/-Trp/-His/+25 mM 3-AT medium (Table 1A) . No growth of Y190 was observed in these plates. To further ensure that neither BD nor AD could independently activate transcription of the reporter genes, the reporter yeast strain Y190 was transformed with either BD or AD vector. The transformation mixture was plated on SD-Leu/-Trp/-His/+25 mM 3-AT agar medium (Table 1A) . There was no growth of Y190, again showing that the activation of transcription of the His-3 gene was due to specific interaction between the {rho}1 and {gamma}2 subunits.


View this table:
[in this window]
[in a new window]
  		Table 1. Growth of Y190 Cells on Synthetic Dropout Media

 
The affinity for protein–protein interaction is indicated in the yeast by the number of primary colonies on SD medium agar plates. There was no significant difference in the number of primary colonies from the {rho}1-BD with {rho}1N'-AD transformation and {rho}1-BD with {gamma}2N'-AD transformation (Table 1B) . This suggests that there is comparable protein–protein affinity between these subunits. The auxotrophic integrity of the Y190 cells was also determined, because the integrity of the reporter yeast strain (Y190) determines the fidelity of the yeast two-hybrid assay. Before each experiment, Y190 cells were transformed with either BD or AD vector, and the transformation mixture was plated on either SD-Trp or SD-Leu, respectively (Table 1C) . Specific growth on these media showed that the reporter yeast strain maintained its auxotrophic integrity.

Functional Interaction of the {gamma}2 N Terminus with the {rho}1 Subunit in Xenopus Oocytes
It has been suggested that there are specific peptide motifs in the N-terminal domain that mediate protein–protein interaction for both homooligomeric and heterooligomeric interactions.52 The competitive inhibition studies in Xenopus oocytes were designed by coinjecting cRNAs of full-length subunits and C-terminal, part-truncated subunits. These C-terminal, part-truncated subunits are mutant receptor/channels that do not have the ability to conduct chloride ions. If there is an assembly occurring among full-length and mutant subunits, the population of functional receptor/channel in the membrane is decreased. Coexpression of the C-terminal, part-truncated mutant of the {rho}1 subunit ({rho}N') with the full-length {rho}1 subunit in oocytes resulted in a cRNA concentration-dependent reduction in GABA-induced whole-cell current (Fig. 4A) . Whether the {gamma}2 subunit interacts with the {rho}1 subunit was investigated by coexpression of the C-terminal, part-truncated mutant of the {gamma}2 subunit ({gamma}N') with the native {rho}1 subunit in Xenopus oocytes. Coinjection of the {rho}1 subunit cRNA with the {gamma}N' mutant in oocytes demonstrated a concentration-dependent inhibition of GABA-induced whole-cell current (Fig. 4B) . The reduction in GABA-induced whole-cell current of the {rho}1 subunit suggests that the N terminus of the {gamma}2 subunit contains motif(s) for heterooligomeric interaction with the {rho}1 subunit.



View larger version (14K):
[in this window]
[in a new window]
  		Figure 4. Determination of GABA {gamma}2 and {rho}1 subunit functional interaction in Xenopus oocytes. (A) Competitive inhibition of GABA-induced {rho}1 subunit activation by C-terminal deletion mutants of the {rho}1 subunit ({rho}N'). There was a proportionate decrease in whole-cell current when the amount of N-terminal {rho}1 cRNA coexpressed with 25 ng full-length {rho}1 cRNA in Xenopus oocytes increased. Data were analyzed by one-way ANOVA (0.05 significance level, n = 44). Top: Representative traces from whole-cell current recordings in Xenopus oocytes. (B) Competitive inhibition of GABA-induced {rho}1 subunit activation by C-terminal deletion mutants of the {gamma}2 subunit ({gamma}N'). There was a proportionate decrease in whole-cell current when the amount of N-terminal {gamma}2 cRNA coexpressed with 25 ng full-length {rho}1 cRNA in Xenopus oocytes increased. Data were analyzed by one-way ANOVA (0.05 significance level, n equals; 40).

 
Altered Pharmacologic Properties of the Recombinant GABAH Receptor/Channel
The plant-derived convulsant bicuculline is a potent antagonist at GABAA receptor/channels. Application of 100 µM bicuculline resulted in a more than 75% reduction of GABA-induced current in oocytes expressing heterooligomeric receptor/channel of the GABAA {alpha}1, ß2, and {gamma}2 subunits, but showed no effect on homooligomeric receptor/channels of the GABAC {rho}1 subunits (data not shown). Application of 100 µM bicuculline showed no effect on recombinant GABAH receptor/channels (assembled by the {gamma}2 and {rho}1 subunits) in Xenopus oocytes (Fig. 5A) . In contrast, I4AA is an antagonist of GABAC receptor/channels in the retina but is an agonist at recombinant GABAC receptor/channels in Xenopus oocytes.3 Application of 100 µM I4AA showed neither agonist nor antagonist effects at recombinant GABAH receptor/channels in Xenopus oocytes (Fig. 5B) . The pharmacologic studies provided additional evidence of the assembly of the {gamma}2 subunit with the {rho}1 subunit in Xenopus oocytes indicating the importance of subunit composition in the diversity of the GABAergic system.



View larger version (14K):
[in this window]
[in a new window]
  		Figure 5. Effects of bicuculline and I4AA on GABA-induced currents in Xenopus oocytes expressing {gamma}2 and {rho}1 subunits. (A) The {rho}1 and {gamma}2 subunits were coexpressed in Xenopus oocytes, and GABA-induced whole-cell currents were recorded by voltage clamp in the presence and absence of the GABAA receptor/channel antagonist bicuculline. Bicuculline showed no effect on the GABA-induced whole-cell currents in oocytes that heteromerically expressed the {gamma}2 and {rho}1 subunits. (B) The {rho}1 and {gamma}2 subunits were coexpressed in Xenopus oocytes, and GABA-induced whole-cell currents were recorded by voltage clamp in the presence and absence of the GABAC receptor/channel agonist/antagonist I4AA. I4AA (100 µM) showed no agonist or antagonist effect on whole-cell currents in oocytes that heteromerically expressed the {gamma}2 and {rho}1 subunits.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Subunit composition determines the pharmacologic and electrophysiological properties of the GABA receptor/channels in the brain. Because the retina is a window of the brain, this study is important as well for understanding the GABA receptor/channels in the retina. The native GABAA receptor/channel is a heterooligomeric and pentameric protein containing {gamma} subunits.52 The GABAC receptor/channel {rho}1 subunit has been expressed in Xenopus oocytes and forms a homooligomeric receptor/channel with a high affinity for GABA and a large ionic conductance of current.4 5 In addition, pharmacologic and electrophysiological profiles of the GABAC receptor/channel are distinct from GABAA receptor/channels. Recently, pharmacologic and electrophysiological studies on some GABA receptor/channels have revealed characteristics different from other GABA receptor/channels. These differences could be due to novel GABA receptor/channels formed by unidentified subunits, splicing variants of cloned subunits, or subunit compositions forming novel hybrid receptor/channels. Considering that some drugs modify CNS responses through their interaction with specific subunits of GABA receptor/channels, a better understanding of their mode of action depends on additional characterization of GABAergic system diversity. Such an understanding can be obtained through further studies on subunit composition of GABA receptor/channels. We undertook in the present study to determine the protein–protein interaction of the GABA {gamma}2 and {rho}1 subunits in vivo.

In vivo expression determined by the yeast two-hybrid and the Xenopus oocyte systems is ideal for studying protein–protein interaction and subunit assembly, because subunits are very likely to be expressed in their native conformations in these systems, as opposed to in vitro translation systems. The other advantage of these systems is that they allow examination of the subunit assembly at the translation level. Because C-terminal, part-truncated mutant subunits can be expressed in these systems, there is an additional advantage of using such systems to determine the specific peptide domain(s) that mediate interaction and assembly of these subunits. The affinity for protein–protein interaction in the yeast two-hybrid system can be determined by counting the number of primary colonies grown in the triple-dropout medium. We found, by using the two-hybrid system, that the {gamma}2 subunit indeed interacts with the {rho}1 subunit and that the affinity of this interaction is similar to the {rho}1-to-{rho}1 subunit interaction to form a homooligomeric receptor/channel. This suggests in neurons expressing both the {gamma}2 and {rho}1 subunit mRNAs that there may be equal possibilities for homooligomeric {rho}1 assembly or heterooligomeric {rho}1/{gamma}2 assembly.

Despite our evidence for assembly and interaction, it is also possible that the reduction in whole-cell current may be due to disruption of translation of the full-length {rho}1 cRNA by the N-terminal cRNA. If this decrease in whole-cell current were due to disruption of translation, one would expect a similar reduction in whole-cell current on coexpressing full-length {rho}1 cRNA with the cRNA of the N-terminal–truncated mutant of the {rho}1 subunit. Coexpression of the N-terminal–truncated {rho}1 mutant cRNA with the full-length {rho}1 cRNA, however, showed no effect on the whole-cell current, compared with homooligomeric {rho}1 expression (data not shown). In fact, increasing the amount of coexpressed {gamma}N' and {rho}N' mutants competitively inhibited GABA-induced currents of the homooligomeric {rho}1 subunit in Xenopus oocytes (Fig. 4) . There are two possible explanations for the competitive inhibition: (1) Coexpression of a truncated mutant with a wild-type subunit in Xenopus oocytes resulted in a population of mutant receptor/channels that may not be translocated to the membrane, or (2) if these mutant receptor/channels were translocated to the membrane, they may not be able to form functional chloride channels because of the absence of channel-forming domains.

The interaction of {gamma}2 and {rho}1 subunits in both the Xenopus oocyte and yeast two-hybrid systems suggests, but does not necessarily imply, that there is assembly of these subunits in the retina and CNS. We therefore used immunoprecipitation to show that there is assembly of these subunits in the retina and CNS. The fidelity of an immunoprecipitation reaction largely depends on whether there are specific and nonspecific posttranslation interactions in the protein clumping. Our data showed that subunit interaction is a cotranslation process rather than a posttranslation process, by using a fusion protein and tissue lysate incubation assay. In addition, we found that the {gamma}2 subunit was immunoprecipitated with the {rho}1 subunit when specific antibodies were used, providing strong indication of assembly of these two subunits. Incubation of GST-{rho}1 fusion protein with brain and spinal cord lysates and with the homogenate from Xenopus oocytes expressing the {rho}1 subunit showed that there was no posttranslation subunit–subunit interaction. More evidence in favor of cotranslation subunit interaction comes from coexpressing full-length {rho}1 subunit with {rho}1 mutants that do not have the N-terminal signal sequence in Xenopus oocytes, by using the voltage recording of GABA-induced whole-cell currents (data not shown). In addition, if interaction of subunits could be a posttranslation process, one would expect the mediation of chaperone proteins, which have never been shown for the ionotropic GABA receptor channel subunits. Cotranslation interaction of these subunits indicates that the subunits assemble in the ER or Golgi to form the receptor/channel complex, which is then translocated to the membrane as a complete unit.

In summary, in our study, we showed, by the yeast two-hybrid expression system, that the {gamma}2 subunit interacted with the {rho}1 subunit, and we also showed, by the Xenopus oocyte expression system, the assembly of these two subunits. Most important, we showed that the {rho}1 and {gamma}2 subunits assembled in the retina and CNS to form a novel hybrid GABA receptor/channel. It is very likely that this hybrid receptor/channel possesses pharmacologic and electrophysiological properties that are distinct from those of GABAA and GABAc receptor/channels. Considering that subunit composition defines GABAergic system properties, additional studies are warranted to explore in the CNS the electrophysiological and pharmacologic profiles of these hybrid GABA receptor/channels.


   Footnotes
 
Supported by the American Physiological Society, a Porter fellowship (GME), and National Eye Institute (NIH) Grant EY11653 (LL).

Submitted for publication November 9, 2001; revised March 8, 2002; accepted March 19, 2002.

Commercial relationships policy: N.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: Luo Lu, Division of Molecular Medicine, UCLA School of Medicine, Harbor-UCLA Medical Center, 1124 W. Carson Street, C-2, Torrance, CA 90502-2006; lluou{at}ucla.edu.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Boue-Grabot, E, Dufy, B, Garret, M. (1995) Molecular diversity of GABA-gated chloride channels in the rat anterior pituitary Brain Res 704,125-129[Medline][Order article via Infotrieve]
  2. Feigenspan, A, Wassle, H, Bormann, J. (1993) Pharmacology of GABA receptor Cl- channels in rat retinal bipolar cells Nature 361,159-162[Medline][Order article via Infotrieve]
  3. Feigenspan, A, Bormann, J. (1994) Modulation of GABAC receptors in rat retinal bipolar cells by protein kinase C J Physiol (Lond) 481,325-330[Medline][Order article via Infotrieve]
  4. Jeong, Y, Baik, EJ, Nam, TS, Paik, KS. (1995) Effects of iontophoretically applied naloxone, picrotoxin and strychnine on dorsal horn neuron activities treated with high frequency conditioning stimulation in cats Yonsei Med J 36,336-347[Medline][Order article via Infotrieve]
  5. Matthews, G, Ayoub, GS, Heidelberger, R. (1994) Presynaptic inhibition by GABA is mediated via two distinct GABA receptors with novel pharmacology J Neurosci 14,1079-1090[Abstract]
  6. Pimentel, J, Pinto, F. (1995) New antiepileptic medications (in Portuguese) Acta Med Port 8,43-48[Medline][Order article via Infotrieve]
  7. Ring, HA, Heller, AJ, Farr, IN, Reynolds, EH. (1990) Vigabatrin: rational treatment for chronic epilepsy J Neurol Neurosurg Psychiatry 53,1051-1055[Abstract]
  8. Sandyk, R. (1995) Resolution of dysarthria in multiple sclerosis by treatment with weak electromagnetic fields Int J Neurosci 83,81-92[Medline][Order article via Infotrieve]
  9. Behar, TN, Li, YX, Tran, HT, et al (1996) GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms J Neurosci 16,1808-1818[Abstract/Free Full Text]
  10. Bonnert, TP, McKernan, RM, Farrar, S, et al (1999) Theta, a novel gamma-aminobutyric acid type A receptor subunit Proc Natl Acad Sci USA 96,9891-9896[Abstract/Free Full Text]
  11. Cutting, GR, Lu, L, O’Hara, BF, et al (1991) Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina Proc Natl Acad Sci USA 88,2673-2677[Abstract/Free Full Text]
  12. Davies, PA, Hanna, MC, Hales, TG, Kirkness, EF. (1997) Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit Nature 385,820-823[Medline][Order article via Infotrieve]
  13. Hedblom, E, Kirkness, EF. (1997) A novel class of GABAA receptor subunit in tissues of the reproductive system J Biol Chem 272,15346-15350[Abstract/Free Full Text]
  14. Kusama, T, Wang, TL, Guggino, WB, Cutting, GR, Uhl, GR. (1993) GABA rho 2 receptor pharmacological profile: GABA recognition site similarities to rho 1 Eur J Pharmacol 245,83-84[Medline][Order article via Infotrieve]
  15. Lolait, SJ, O’Carroll, AM, Kusano, K, Muller, JM, Brownstein, MJ, Mahan, LC. (1989) Cloning and expression of a novel rat GABAA receptor FEBS Lett 246,145-148[Medline][Order article via Infotrieve]
  16. Macdonald, RL, Olsen, RW. (1994) GABAA receptor channels Annu Rev Neurosci 17,569-602[Medline][Order article via Infotrieve]
  17. Olsen, RW, Wamsley, JK, Lee, RJ, Lomax, P. (1986) Benzodiazepine/barbiturate/GABA receptor-chloride ionophore complex in a genetic model for generalized epilepsy Adv Neurol 44,365-378[Medline][Order article via Infotrieve]
  18. Schofield, PR, Darlison, MG, Fujita, N, et al (1987) Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family Nature 328,221-227[Medline][Order article via Infotrieve]
  19. Shimada, S, Cutting, G, Uhl, GR. (1992) gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine- insensitive gamma-aminobutyric acid responses in Xenopus oocytes Mol Pharmacol 41,683-687[Abstract]
  20. Benke, D, Fritschy, JM, Trzeciak, A, Bannwarth, W, Mohler, H. (1994) Distribution, prevalence, and drug binding profile of gamma- aminobutyric acid type A receptor subtypes differing in the beta- subunit variant J Biol Chem 269,27100-27107[Abstract/Free Full Text]
  21. Burt, DR, Kamatchi, GL. (1991) GABAA receptor subtypes: from pharmacology to molecular biology FASEB J 5,2916-2923[Abstract]
  22. Sanna, E, Garau, F, Harris, RA. (1995) Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital Mol Pharmacol 47,213-217[Abstract]
  23. Sigel, E, Baur, R, Trube, G, Mohler, H, Malherbe, P. (1990) The effect of subunit composition of rat brain GABAA receptors on channel function Neuron 5,703-711[Medline][Order article via Infotrieve]
  24. Verdoorn, TA, Draguhn, A, Ymer, S, Seeburg, PH, Sakmann, B. (1990) Functional properties of recombinant rat GABAA receptors depend upon subunit composition Neuron 4,919-928[Medline][Order article via Infotrieve]
  25. Zhang, D, Pan, ZH, Zhang, X, Brideau, AD, Lipton, SA. (1995) Cloning of a gamma-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block Proc Natl Acad Sci USA 92,11756-11760[Abstract/Free Full Text]
  26. Olsen, RW, Tobin, AJ. (1990) Molecular biology of GABAA receptors FASEB J 4,1469-1480[Abstract]
  27. Polenzani, L, Woodward, RM, Miledi, R. (1991) Expression of mammalian gamma-aminobutyric acid receptors with distinct pharmacology in Xenopus oocytes Proc Natl Acad Sci USA 88,4318-4322[Abstract/Free Full Text]
  28. Enz, R, Cutting, GR. (1999) GABAC receptor rho subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct physical properties Eur J Neurosci 11,41-50[Medline][Order article via Infotrieve]
  29. Martina, M, Strata, F, Cherubini, E. (1995) Whole cell and single channel properties of a new GABA receptor transiently expressed in the Hippocampus J Neurophysiol 73,902-906[Abstract/Free Full Text]
  30. Strata, F, Cherubini, E. (1994) Transient expression of a novel type of GABA response in rat CA3 hippocampal neurones during development J Physiol (Lond) 480,493-503[Medline][Order article via Infotrieve]
  31. Drew, CA, Johnston, GA, Weatherby, RP. (1984) Bicuculline-insensitive GABA receptors: studies on the binding of (-)- baclofen to rat cerebellar membranes Neurosci Lett 52,317-321[Medline][Order article via Infotrieve]
  32. Drew, CA, Johnston, GA. (1992) Bicuculline- and baclofen-insensitive gamma-aminobutyric acid binding to rat cerebellar membranes J Neurochem 58,1087-1092[Medline][Order article via Infotrieve]
  33. Wegelius, K, Pasternack, M, Hiltunen, JO, et al (1998) Distribution of GABA receptor rho subunit transcripts in the rat brain Eur J Neurosci 10,350-357[Medline][Order article via Infotrieve]
  34. McDonald, BJ, Moss, SJ. (1994) Differential phosphorylation of intracellular domains of gamma- aminobutyric acid type A receptor subunits by calcium/calmodulin type 2-dependent protein kinase and cGMP-dependent protein kinase J Biol Chem 269,18111-18117[Abstract/Free Full Text]
  35. Machu, TK, Olsen, RW, Browning, MD. (1993) Immunochemical characterization of the beta 2 subunit of the GABAA receptor J Neurochem 61,2034-2040[Medline][Order article via Infotrieve]
  36. Harvey, RJ, Schmitt, B, Hermans-Borgmeyer, I, Gundelfinger, ED, Betz, H, Darlison, MG. (1994) Sequence of a Drosophila ligand-gated ion-channel polypeptide with an unusual amino-terminal extracellular domain J Neurochem 62,2480-2483[Medline][Order article via Infotrieve]
  37. Sieghart, W. (1992) GABAA receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites Trends Pharmacol Sci 13,446-450[Medline][Order article via Infotrieve]
  38. Sivilotti, L, Nistri, A. (1989) Pharmacology of a novel effect of gamma-aminobutyric acid on the frog optic tectum in vitro Eur J Pharmacol 164,205-212[Medline][Order article via Infotrieve]
  39. Amin, J, Dickerson, IM, Weiss, DS. (1994) The agonist binding site of the gamma-aminobutyric acid type A channel is not formed by the extracellular cysteine loop Mol Pharmacol 45,317-323[Abstract]
  40. McKinley, DD, Lennon, DJ, Carter, DB. (1995) Cloning, sequence analysis and expression of two forms of mRNA coding for the human beta 2 subunit of the GABAA receptor Brain Res Mol Brain Res 28,175-179[Medline][Order article via Infotrieve]
  41. Thompson, CL, Stephenson, FA. (1994) GABAA receptor subtypes expressed in cerebellar granule cells: a developmental study J Neurochem 62,2037-2044[Medline][Order article via Infotrieve]
  42. Kofuji, P, Wang, JB, Moss, SJ, Huganir, RL, Burt, DR. (1991) Generation of two forms of the gamma-aminobutyric acidA receptor gamma 2-subunit in mice by alternative splicing J Neurochem 56,713-715[Medline][Order article via Infotrieve]
  43. Zheng, TM, Zhu, WJ, Puia, G, et al (1994) Changes in gamma-aminobutyrate type A receptor subunit mRNAs, translation product expression, and receptor function during neuronal maturation in vitro Proc Natl Acad Sci USA 91,10952-10956[Abstract/Free Full Text]
  44. Ekema, G, Lu, L. (1999) The N-terminal domain contains motifs for assembly between the GABAC receptor/channel {rho}1 subunit and the GABAA receptor/channel ß2 and {gamma}2 subunits Invest Ophthalmol Vis Sci 40,S442Abstract nr 2335
  45. Martinez-Torres, A, Demuro, A, Miledi, R. (2000) GABArho 1/GABAAalpha 1 receptor chimeras to study receptor desensitization Proc Natl Acad Sci USA 97,3562-3566[Abstract/Free Full Text]
  46. Pan, ZH, Zhang, D, Zhang, X, Lipton, SA. (2000) Evidence for coassembly of mutant GABAC rho1 with GABAA gamma2S, glycine alpha1 and glycine alpha2 receptor subunits in vitro Eur J Neurosci 12,3137-3145[Medline][Order article via Infotrieve]
  47. Ekema, GM, Zheng, W, Wang, L, Lu, L. (2001) Modulation of recombinant GABA receptor/channel subunits by domain specific antibodies in Xenopus oocytes J Membr Biol 183,215-223
  48. Fields, S, Song, O. (1989) A novel genetic system to detect protein–protein interactions Nature 340,245-246[Medline][Order article via Infotrieve]
  49. Gietz, D, St. Jean, A, Woods, RA, Schiestl, RH. (1992) Improved method for high efficiency transformation of intact yeast cells Nucleic Acids Res 20,1425[Free Full Text]
  50. Shivers, BD, Killisch, I, Sprengel, R, et al (1989) Two novel GABAA receptor subunits exist in distinct neuronal subpopulations Neuron 3,327-337[Medline][Order article via Infotrieve]
  51. Sigel, E, Baur, R, Kellenberger, S, Malherbe, P. (1992) Point mutations affecting antagonist affinity and agonist dependent gating of GABAA receptor channels EMBO J 11,2017-2023[Medline][Order article via Infotrieve]
  52. Hackam, AS, Wang, TL, Guggino, WB, Cutting, GR. (1997) The N-terminal domain of human GABA receptor rho1 subunits contains signals for homooligomeric and heterooligomeric interaction J Biol Chem 272,13750-13757[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Physiol.Home page
V. L. Harvey, I. C. Duguid, C. Krasel, and G. J. Stephens
Evidence that GABA {rho} subunits contribute to functional ionotropic GABA receptors in mouse cerebellar Purkinje cells
J. Physiol., November 15, 2006; 577(1): 127 - 139.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. J. Milligan, N. J. Buckley, M. Garret, J. Deuchars, and S. A. Deuchars
Evidence for Inhibition Mediated by Coassembly of GABAA and GABAC Receptor Subunits in Native Central Neurons
J. Neurosci., August 18, 2004; 24(33): 7241 - 7250.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Zheng, W. Xie, J. Zhang, J. A. Strong, L. Wang, L. Yu, M. Xu, and L. Lu
Function of {gamma}-Aminobutyric Acid Receptor/Channel {rho}1 Subunits In Spinal Cord
J. Biol. Chem., November 28, 2003; 278(48): 48321 - 48329.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map